Related Experiment Videos
Cyclin E -- a better prognostic marker for breast cancer than cyclin D?
Nature Medicine
|March 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.
Current cancer drug targets·2011
Green tea polyphenols as proteasome inhibitors: implication in chemoprevention.
Current cancer drug targets·2011
AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.
American journal of rhinology & allergy·2026
Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.
The Journal of international medical research·2026
Combining Statistical Modeling and Machine Learning for Prognostic Feature Selection in Cervical Cancer: A Retrospective Study Based on SEER 2004 to 2015 Data.
American journal of clinical oncology·2026